Press Releases

Year

04 Aug '22

Allscripts Announces Second Quarter of 2022 Results

Second quarter bookings of $107 million and $172 million year-to-date, up 10% from the first half of 2021 Generated $42 million of cash flow from continuing operations in the quarter CHICAGO --(BUSINESS WIRE)--Aug. 4, 2022-- Allscripts Healthcare Solutions, Inc.

PDF Version

21 Jul '22

Allscripts to Release Second-Quarter 2022 Financial Results August 4

CHICAGO --(BUSINESS WIRE)--Jul. 21, 2022-- Allscripts Healthcare Solutions, Inc . (NASDAQ: MDRX) will report its financial results for the three months ended June 30, 2022 after the close of stock market hours on Thursday, August 4, 2022 . Allscripts management plans to host a conference call and

PDF Version

19 Jul '22

Pulse8 Receives NCQA Measure Certification™ for HEDIS® MY2022 for Qualit8™, a Veradigm Network Solution

CHICAGO --(BUSINESS WIRE)--Jul. 19, 2022-- Pulse8 is thrilled to announce that Qualit8, a Veradigm Network Solution, has achieved MY2022 Measure Certification from the National Committee for Quality Assurance (NCQA) for the third consecutive year. Veradigm ® is a leading provider of healthcare

PDF Version

29 Jun '22

Veradigm Issued Patent for Risk Adjustment Method and Apparatus

Veradigm is providing health plans with a patent-protected method to support risk adjustment programs through “Dynamic Intervention Planning” CHICAGO --(BUSINESS WIRE)--Jun. 29, 2022-- Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and

PDF Version

11 May '22

Veradigm Presentations at ISPOR 2022 Highlight Broader Access to and Integration of Real-world Data Sources

Covid-19 Dashboard highlights risk factors for unvaccinated, vaccination gaps, and social disparities CHICAGO --(BUSINESS WIRE)--May 11, 2022-- Researchers from Veradigm ® , a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR)

PDF Version

05 May '22

Allscripts Announces First Quarter of 2022 Results

First quarter GAAP diluted EPS of $0.17 ; non-GAAP diluted EPS of $0.13 Closed the sale of Hospital & Large Physician Practices business segment to Constellation Software Generated $35 million of cash flow from continuing operations in the quarter CHICAGO --(BUSINESS WIRE)--May 5, 2022-- Allscripts

PDF Version

02 May '22

Allscripts Closes Sale of Hospital and Large Physician Practices Business to Constellation Software

CHICAGO --(BUSINESS WIRE)--May 2, 2022-- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) today announced that it has completed the sale of the net assets of the Allscripts Hospital and Large Physician Practices business segment to Constellation Software Inc.

PDF Version

21 Apr '22

Allscripts to Release First-Quarter 2022 Financial Results May 5

CHICAGO --(BUSINESS WIRE)--Apr. 21, 2022-- Allscripts Healthcare Solutions, Inc . (NASDAQ:MDRX) will report its financial results for the three months ended March 31, 2022 after the close of stock market hours on Thursday, May 5, 2022 . Allscripts management plans to host a conference call and

PDF Version

07 Mar '22

Allscripts Introduces New App Expo to Showcase a Broader Range of Integrated Solutions

Formerly known as the Allscripts Application Store , the refreshed site includes global tags and dedicated pages to promote even more certified applications CHICAGO --(BUSINESS WIRE)--Mar. 7, 2022-- Allscripts (NASDAQ: MDRX) announced today that its Application Store has been relaunched as the

PDF Version

02 Mar '22

Allscripts to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software

CHICAGO --(BUSINESS WIRE)--Mar. 2, 2022-- Allscripts Healthcare Solutions (NASDAQ: MDRX) (“Allscripts”) announced today that it has reached an agreement with Constellation Software Inc. (TSX:CSU), through its wholly-owned subsidiary N. Harris Computer Corporation (“Harris”), to sell Harris the net

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Press Releases

Press Releases

Contact Investor Relations

Request E-mail Alerts